Arthur M. Krieg is CSO at Checkmate Pharmaceuticals, Inc. (CMPI). They have made 13 open-market trades across 2 companies since 2006, most recently 2021-06-18.
CIK 0001335659
10 open-market purchases totalling $1.8M since 2020, against 3 sales. Across 10 scored buys the stock is down 31.8% at ninety days, and 39.1 points behind the S&P over the same stretch.
10 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 50% | 20% | 10% |
| Avg Move | -5.5% | -13.6% | -31.8% |
| Alpha | -7.6% | -16.3% | -39.1% |
| Scored | 10 | 10 | 10 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CMPI | BUY | 2021-06-18 | 2021-06-21 | $6.04 | $44K | -1.7% | -9.7% | -24.3% |
| CMPI | BUY | 2021-06-16 | 2021-06-17 | $6.18 | $22K | +1.1% | -15.4% | -26.0% |
| CMPI | BUY | 2021-05-18 | 2021-05-19 | $6.97 | $349K | -5.4% | -13.8% | -29.1% |
| CMPI | BUY | 2021-03-29 | 2021-03-31 | $11.16 | $741K | -43.0% | -43.1% | -51.5% |
| CMPI | BUY | 2021-03-25 | 2021-03-29 | $12.32 | $290K | -10.1% | -45.2% | -45.6% |
| CMPI | BUY | 2021-01-27 | 2021-01-28 | $13.05 | $22K | +0.2% | -7.9% | -56.3% |
| CMPI | BUY | 2021-01-19 | 2021-01-21 | $13.09 | $7K | +8.9% | +4.1% | -55.0% |
| CMPI | BUY | 2020-12-29 | 2020-12-31 | $14.16 | $6K | -7.7% | +9.0% | -17.8% |
| CMPI | BUY | 2020-12-22 | 2020-12-23 | $14.64 | $149K | +2.0% | -2.0% | -12.9% |
| CMPI | BUY | 2020-12-15 | 2020-12-17 | $14.62 | $141K | +0.5% | -11.7% | +0.1% |
| COLY | SELL | 2007-08-29 | 2007-08-29 | $1.89 | $40K | N/A | N/A | N/A |
| COLY | SELL | 2006-12-07 | 2006-12-11 | $2.24 | $41K | N/A | N/A | N/A |
| COLY | SELL | 2006-10-13 | 2006-10-16 | $1.89 | $25K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.